Assignee
IMMATICS US INC
US·9 granted patents·24 pending applications·4 citations·filing 2018–2025
Top patents by PatentIndex Score
33 records- 0182US11851673B2WPRE mutant constructs, compositions, and methods thereofIMMATICS US INC·Filed 2021·Granted Dec 26, 2023·1 cites·20 claims
- 0279US2026000734A1METHODS FOR EXPANDING AND ACTIVATING yo T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIESIMMATICS US INC·Filed 2025·Application pending·0 cites
- 0378US12123013B2WPRE mutant constructs, compositions, and methods thereofIMMATICS US INC·Filed 2023·Granted Oct 22, 2024·0 cites·19 claims
- 0477US12440541B2Methods for expanding and activating γσ T cells for the treatment of cancer and related malignanciesIMMATICS US INC·Filed 2023·Granted Oct 14, 2025·0 cites·19 claims
- 0576US2025075230A1Wpre mutant constructs, compositions, and methods thereofIMMATICS US INC·Filed 2024·Application pending·0 cites
- 0674US11464800B2Methods for manufacturing T cellsIMMATICS US INC·Filed 2019·Granted Oct 11, 2022·3 cites·20 claims
- 0772US2025034588A1Methods of assessing potency of viral vectorsIMMATICS US INC·Filed 2024·Application pending·0 cites
- 0868US2025051418A1Viral vectors and use thereof in adoptive cellular therapyIMMATICS US INC·Filed 2024·Application pending·0 cites
- 0965US11690872B2Methods for expanding and activating γδ T cells for the treatment of cancer and related malignanciesIMMATICS US INC·Filed 2018·Granted Jul 4, 2023·0 cites·16 claims
- 1065US2025019655A1Cd28 t cell cultures, compositions, and methods of using thereofIMMATICS US INC·Filed 2024·Application pending·0 cites
- 1163US2025002855A1Methods for expanding t cells for the treatment of cancer and related malignanciesIMMATICS US INC·Filed 2024·Application pending·0 cites
- 1262US2024358831A1Selection of immune cells using peptide mhc complexes generated by conditional ligand exchangeIMMATICS US INC·Filed 2022·Application pending·0 cites
- 1360US2023355678A1Methods for improving t cell efficacyIMMATICS US INC·Filed 2023·Application pending·0 cites
- 1460US2021017492A1Use of retinoic acid in t-cell manufacturingIMMATICS US INC·Filed 2020·Application pending·0 cites
- 1559US11975025B2Viral vectors and use thereof in adoptive cellular therapyIMMATICS US INC·Filed 2020·Granted May 7, 2024·0 cites·16 claims
- 1659US11905529B2Method of enhancing persistence of adoptively infused T cellsIMMATICS US INC·Filed 2020·Granted Feb 20, 2024·0 cites·20 claims
- 1758US12234473B2CD8 polypeptides, compositions, and methods of using thereofIMMATICS US INC·Filed 2021·Granted Feb 25, 2025·0 cites·12 claims
- 1858US2020318068A1Use of retinoic acid in t-cell manufacturingIMMATICS US INC·Filed 2020·Application pending·0 cites
- 1958US2025134931A1Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereofIMMATICS US INC·Filed 2024·Application pending·0 cites
- 2057US2023089392A1Monocyte depletion of t cells populations for t-cell therapyIMMATICS US INC·Filed 2022·Application pending·0 cites
- 2157US2023348548A1Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereofIMMATICS US INC·Filed 2023·Application pending·0 cites
- 2255US2024066127A1Il-12 polypeptides, il-15 polypeptides, il-18 polypeptides, cd8 polypeptides, compositions, and methods of using thereofIMMATICS US INC·Filed 2023·Application pending·0 cites
- 2354US12011459B2Methods for manufacturing T cells by direct sorting and compositions thereofIMMATICS US INC·Filed 2020·Granted Jun 18, 2024·0 cites·14 claims
- 2454US2023348561A1Dominant negative tgfbeta receptor polypeptides, cd8 polypeptides, cells, compositions, and methods of using thereofIMMATICS US INC·Filed 2023·Application pending·0 cites
- 2553US2021041454A1Methods for peptide mass spectrometry fragmentation predictionIMMATICS US INC·Filed 2020·Application pending·0 cites
- 2653US2023142468A1Methods for generating cell spheroidsIMMATICS US INC·Filed 2022·Application pending·0 cites
- 2752US2021030803A1Methods for manufacturing t cellsIMMATICS US INC·Filed 2020·Application pending·0 cites
- 2852US2022280564A1Methods for expanding t cells for the treatment of cancer and related malignanciesIMMATICS US INC·Filed 2021·Application pending·0 cites
- 2951US2019216852A1Methods of assessing potency of viral vectorsIMMATICS US INC·Filed 2019·Application pending·0 cites
- 3050US2019292520A1Method of enhancing persistence of adoptively infused t cellsIMMATICS US INC·Filed 2019·Application pending·0 cites
- 3150US2022056411A1Methods for isolating cd8+ selected t cellsIMMATICS US INC·Filed 2021·Application pending·0 cites
- 3243US2020297768A1Cd28 t cell cultures, compositions, and methods of using thereofIMMATICS US INC·Filed 2020·Application pending·0 cites
- 3339US2025146019A1Cd8 polypeptides, compositions, and methods of using thereofIMMATICS US INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMMATICS US INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →